Inside this issueCover storiesA passionate ventureNew PET Center will aid drug developmentA 'country doctor' gives back to Yale by aiding studentsPartnershipsHigh school partnership celebrates 10 yearsGrants & contractsPeopleLifelines: Kenneth MillerCell-signaling expert will lead vascular biologyMedical oncologist is appointed deputy director of Cancer CenterImmunobiology chair is named to Institute of MedicineScientist is honored by foundation for research on lupusOut & aboutAwards & honorsScienceImmunology comes of age at medical schoolYale research makes Science's 'top 10' listAdvances: Breathing easier about lung injury? | Changes in Medicare help prevent cancers | Inclined by genes toward nicotine | Missing molecule puts neurons off track  
|
|
Medical oncologist is appointed deputy director of Cancer Center
Yale Cancer Center (YCC) is expanding, and so is the role of Edward Chu, M.D. Chu has been appointed deputy director of YCC, where Edward Chu he will also continue to direct the center’s clinical research initiatives and serve as chief of medical oncology. Chu, professor of medicine and pharmacology, graduated from Brown University with undergraduate, master’s and medical degrees. He came to Yale in 1996 from the National Cancer Institute, where he was a tenured senior clinical investigator. He is internationally known for his research on tumor resistance to chemotherapy and on new compounds for colorectal cancer. Over the last two years, Chu has recruited 11 clinical investigators from around the country as part of his plan to transform Yale into a center of translational research. “Ed’s experience and dedication will be a tremendous asset as Yale Cancer Center continues to grow and enters a new phase of expansion with the opening of our new clinical facility in 2009,” said YCC Director Richard L. Edelson, M.D. Chu moves into his new position in the footsteps of José Costa, M.D.,
who helped lead the center for 10 years, developing research programs and guiding
YCC through two comprehensive grant submissions to the National Cancer Institute.
Costa, professor of pathology and medicine, remains an active member of the
Cancer Center and vice chair of the Department of Pathology.  |
|||
